Loading insider details...
Beta
Latest Form 4 (Jul 7, 2026): Exercise/Conversion of 7,211 INMB shares, $10.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 7, 2026 | Inmune Bio, Inc. (INMB) | Exercise/Conversion | 7,211 | $10.1K |
| Dec 2, 2025 | Inmune Bio, Inc. (INMB) | Grant/Award | 600,000 | n/a |
| Nov 18, 2025 | Inmune Bio, Inc. (INMB) | Disposition to Issuer | 400,000 | n/a |
| Dec 9, 2024 | Inmune Bio, Inc. (INMB) | Grant/Award | 140,000 | n/a |
| May 16, 2024 | Inmune Bio, Inc. (INMB) | Grant/Award | 100,000 | n/a |
| Apr 23, 2024 | Inmune Bio, Inc. (INMB) | Grant/Award | 14,423 | $120.0K |
| Mar 23, 2022 | Inmune Bio, Inc. (INMB) | Grant/Award | 23,590 | $198.9K |
| Nov 4, 2021 | Inmune Bio, Inc. (INMB) | Sale | 701 | $14.0K |
| Oct 29, 2021 | Inmune Bio, Inc. (INMB) | Sale | 2,357 | $47.1K |
| Oct 26, 2021 | Inmune Bio, Inc. (INMB) | Sale | 400 | $8.0K |